Company / Accounts Receivable
Teladoc Health, Inc. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$192.8M
FY2025
5-year range
$169.0M / $217.4M
FY2021-FY2025
Trend
-10.0%
vs FY2024
Sector context
#75 of 143
Health Care
What the data says
At $193M, Teladoc Health, Inc.'s accounts receivable ranks #75 of 143 in the Health Care sector. Accounts Receivable has fluctuated over the past 10 years, ranging from $14M in FY2016 to $217M in FY2023.
Based on SEC 10-K filings.
$193M in FY2025 with a 5-year CAGR of +2.6%.
Declined from $217M to $193M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -2.9%
- 5-Year CAGR
- +2.6%
- 10-Year CAGR
- -
Sector benchmark
#75 of 143 in Health CareTop 52% of 143This company $192.8M Sector average $1.3B
▼
-85.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.6%, indicating consistent growth.
- In FY2025, accounts receivable decreased 10.0% year-over-year.
- Ranks #75 out of 143 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $192.8M | -10.0% |
| FY2024 | $214.1M | -1.5% |
| FY2023 | $217.4M | +3.3% |
| FY2022 | $210.6M | +24.6% |
| FY2021 | $169.0M | -0.2% |
| FY2020 | $169.3M | +197.3% |
| FY2019 | $56.9M | +30.7% |
| FY2018 | $43.6M | +60.8% |
| FY2017 | $27.1M | +96.2% |
| FY2016 | $13.8M | +13.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026